Association of myeloid-derived suppressor cells with hematopoietic recovery after high-dose chemotherapy in multiple myeloma

Association of myeloid-derived suppressor cells with hematopoietic recovery after high-dose chemotherapy in multiple myeloma

Myeloid-derived suppressor cells (MDSCs) play an important role in the immune response regulation in many pathologies, primarily in malignant tumors, but their role in the hematopoietic stem cell engraftment and the hematopoietic recovery after high-dose chemotherapy and autologous stem cell transpl...

Full description

Saved in:

Bibliographic Details
Main Authors:	V. S. Anmut, T. V. Tyrinova, E. V. Batorov, T. A. Aristova, S. A. Sizikova, G. Yu. Ushakova, V. V. Denisova, E. R. Chernykh
Format:	Article
Language:	Russian
Published:	St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists 2023-06-01
Series:	Медицинская иммунология
Subjects:	myeloid-derived suppressor cells multiple myeloma transplantation hematopoietic stem cells duration of leukopenia early hematopoietic recovery
Online Access:	https://www.mimmun.ru/mimmun/article/view/2700
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Myeloid-derived suppressor cells in multiple myeloma patients at the immune recovery and after high-dose chemotherapy and hematopoietic stem cell transplantation
by: T. V. Tyrinova, et al.
Published: (2023-01-01)

Myeloid-Derived Suppressor Cells in Some Oncohematological Diseases
by: AV Ponomarev
Published: (2017-01-01)

Autologous Hematopoietic Cell Transplant as an Effective Treatment Modality for Systemic Sclerosis and Multiple Myeloma
by: Memon H, et al.
Published: (2025-01-01)

The use of non-cryopreserved hematopoietic stem cells for autologous transplantation in multiple myeloma patients
by: S. V. Voloshin, et al.
Published: (2022-04-01)

Therapy efficacy in multiple myeloma patients received autologous stem cells transplantation as first line therapy
by: Ye. I. Darskaya, et al.
Published: (2014-07-01)

Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma in the Era of New Drugs
by: OV Pirogova, et al.
Published: (2018-04-01)

Current status of hematopoietic stem cell transplant in chronic myeloid leukemia
by: Alok Gupta, et al.
Published: (2014-01-01)

Certain Aspects of Autologous Hematopoietic Stem Cell Transplantation in Patients with Multiple Myeloma
by: SV Gritsaev, et al.
Published: (2017-01-01)

Experience with the Use of Thio/Mel Conditioning Regimen Prior to Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma
by: SV Gritsaev, et al.
Published: (2019-05-01)

How to reduce the risk of primary engraftment failure after haploidentical hematopoietic stem cell transplantation in patients with acute myeloid leukemia?
by: D. K. Zhogolev, et al.
Published: (2025-03-01)

Myeloid-derived suppressor cells in secondary sepsis: Is there an association with lethal outcome?
by: Udovičić Ivo, et al.
Published: (2020-01-01)

The impact of multiple myeloma drugs treatments on autologous stem cell transplantation in the era of new drugs
by: Xixi Wan, et al.
Published: (2025-02-01)

Aging modulates the immunosuppressive, polarizing and metabolic functions of blood-derived myeloid-derived suppressor cells (MDSCs)
by: Emma Keltsch, et al.
Published: (2025-07-01)

The role of myeloid-derived suppressor cells in children
by: Jordan Brauner, et al.
Published: (2025-02-01)

Case report: pomalidomide as maintenance after salvage autologous stem cell transplantation in a patient with relapsed multiple myeloma
by: S. V. Semochkin, et al.
Published: (2023-12-01)

THE EFFICACY OF HIGH-DOSE CONSOLIDATION AND AUTOLOGOUS BONE MARROW TRANSPLANTATION IN FIRST REMISSION OF ACUTE MYELOID LEUKEMIA
by: I. A. Samorodova, et al.
Published: (2018-05-01)

Netupitant / palonosetron with dexamethasone for preventing nausea and vomiting in patients with multiple myeloma receiving high-dose melphalan for autologous hematopoietic stem cell transplantation: a single-center experience
by: N. E Mochkin, et al.
Published: (2025-03-01)

Myeloid-derived suppressor cells in axial spondyloarthritis patients with different types of therapy
by: A. Yu. Morenkova, et al.
Published: (2024-06-01)

Factors associated with the number of CD34-positive hematopoietic progenitor cells in the leukocyte concentrate in patients with lymphomas and acute T-lymphoblastic leukemia
by: I. V. Galtseva, et al.
Published: (2024-12-01)

Clinical outcomes of allogeneic hematopoietic stem cell transplant with different stem cell sources in infant acute myeloid leukemia
by: Yuyang Wang, et al.
Published: (2025-07-01)

Editorial: Hematopoietic stress in stem cell homeostasis and disease pathogenesis
by: Jing Ma, et al.
Published: (2025-03-01)

Bone marrow MRI after autologous transplantation and the effect of residual tumor on progression-free survival of multiple myeloma patients
by: M. V. Solovev, et al.
Published: (2019-01-01)

Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemias with Hyperdiploid Karyotype
by: TL Gindina, et al.
Published: (2016-10-01)

The role of pomalidomide in treatment of relapse and refractory multiple myeloma
by: S. V. Voloshin, et al.
Published: (2022-01-01)

CHARACTERISTICS OF BONE MARROW MICROENVIRONMENT IN MULTIPLE MYELOMA BEFORE AND AFTER TREATMENT
by: V. I. Rugal, et al.
Published: (2019-03-01)

The efficacy and safety of plerixafor in hematopoietic stem cell mobilization in patients with Non-Hodgkin lymphoma, multiple myeloma, and Hodgkin lymphoma who failed mobilization with granulocyte-colony-stimulating factor alone: A single-center experience
by: Girish Badarkhe, et al.
Published: (2020-01-01)

Recombinant human thrombopoietin does not promote platelet engraftment in newly diagnosed multiple myeloma patients following autologous stem cell transplantation
by: Ruiqi Wang, et al.
Published: (2025-02-01)

Autologous hematopoietic stem cell transplantation in remission consolidation of acute myeloid leukemia with initially unfavorable prognostic factors
by: G. D. Petrova, et al.
Published: (2016-03-01)

Chronic myeloid leukemia — before and after imatinib (First part)
by: E. G. Lomaia, et al.
Published: (2022-11-01)

Time to progression predicts outcome of patients with multiple myeloma that can be influenced by autologous hematopoietic stem cell transplantation
by: Yanhua Yue, et al.
Published: (2025-12-01)

The Recruitment and Immune Suppression Mechanisms of Myeloid‐Derived Suppressor Cells and Their Impact on Bone Metastatic Cancer
by: Chengyuan Li, et al.
Published: (2025-02-01)

Haploidentical Hematopoietic Stem Cell Transplantation for Relapsed/Refractory Extramedullary Multiple Myeloma: A Conditioning Regimen Combining Selinexor and Helical Tomotherapy—A Case Report and Literature Review
by: Chen B, et al.
Published: (2025-04-01)

Mindfulness vs. sleep education during autologous hematopoietic cell transplantation for multiple myeloma: Feasibility of a randomized controlled pilot study
by: Elisabeth C. Henley, et al.
Published: (2025-10-01)

Autologous hematopoietic stem cell transplantation in the treatment of systemic sclerosis. Part 1. Clinical aspects
by: O. B. Ovsyannikova, et al.
Published: (2020-11-01)

Results of allogeneic hematopoietic stem cell transplantation in a patient with classical Hodgkin's lymphoma
by: A. Р. Strelnikova, et al.
Published: (2021-05-01)

The role of myeloid-derived suppressor cells in the pathogenesis of rheumatoid arthritis; anti- or pro-inflammatory cells?
by: Misagh Rajabinejad, et al.
Published: (2019-12-01)

Protocol AML-MM-2000 treatment results of unfavorable prognostic group in children with acute myeloid leukemia
by: N. P. Kirsanova, et al.
Published: (2022-11-01)

Posttransplant Erythrocytosis after Allogenic Stem Cell Transplant for Acute Myeloid Leukemia: A Case Report and Review of Literature
by: Sherry S. Abraham, et al.

Comparison of autologous hematopoietic cell transplantation, matched sibling donor hematopoietic cell transplantation, and chemotherapy in patients with favorable- and intermediate-risk acute myeloid leukemia
by: Mingyang Wang, et al.
Published: (2025-01-01)

Clinical Effects of RUNX1 Mutations on the Outcomes of Patients with Acute Myeloid Leukemia Treated with Allogeneic Hematopoietic Stem-Cell Transplantation
by: Wei-Jie Ran, et al.
Published: (2025-05-01)